Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes

Summary

Neuronetics appointed Nir Naor as Chief Financial Officer effective July 23, 2026. Naor brings more than 20 years of finance and life-sciences experience, most recently as CFO of Axogen where he helped achieve profitability and cash-flow positivity, and previously as CFO of Arbor Pharmaceuticals and Mölnlycke’s U.S./Americas business. The appointment strengthens financial discipline as Neuronetics scales its NeuroStar TMS therapy and Greenbrook interventional psychiatry clinic network.